News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
840,377 Results
Type
Article (86108)
Company Profile (702)
Press Release (753567)
Section
Business (232508)
Career Advice (4123)
Deals (39702)
Drug Delivery (127)
Drug Development (90869)
Employer Resources (195)
FDA (18049)
Job Trends (17304)
News (396082)
Policy (39674)
Tag
Academia (2981)
Alliances (56714)
Alzheimer's disease (1430)
Approvals (18001)
Artificial intelligence (271)
Bankruptcy (400)
Best Places to Work (12633)
Biotechnology (481)
Breast cancer (251)
Cancer (1910)
Cardiovascular disease (154)
Career advice (3524)
CAR-T (147)
Cell therapy (426)
Clinical research (72702)
Collaboration (749)
Compensation (389)
COVID-19 (2844)
C-suite (186)
Data (1730)
Diabetes (243)
Diagnostics (6847)
Earnings (95615)
Employer resources (166)
Events (128582)
Executive appointments (622)
FDA (19047)
Funding (672)
Gene therapy (297)
GLP-1 (788)
Government (5095)
Healthcare (20851)
Infectious disease (2974)
Interviews (811)
IPO (17772)
Job creations (5183)
Job search strategy (2860)
Layoffs (524)
Legal (10089)
Lung cancer (279)
Manufacturing (280)
Medical device (14529)
Medtech (14534)
Mergers & acquisitions (22306)
Metabolic disorders (655)
Neuroscience (1906)
NextGen: Class of 2025 (7677)
Non-profit (5077)
Northern California (2225)
Obesity (361)
Opinion (264)
Patents (186)
People (64850)
Pharmaceutical (143)
Phase I (22424)
Phase II (31576)
Phase III (23773)
Pipeline (804)
Postmarket research (3551)
Preclinical (10058)
Radiopharmaceuticals (265)
Rare diseases (370)
Real estate (7382)
Regulatory (26450)
Research institute (2651)
Resumes & cover letters (649)
Southern California (1928)
Startups (4284)
United States (20517)
Vaccines (729)
Weight loss (274)
Date
Today (10)
Last 7 days (943)
Last 30 days (2979)
Last 365 days (37345)
2025 (5917)
2024 (38138)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1269)
Arizona (248)
Asia (49805)
Australia (8778)
California (5209)
Canada (1783)
China (438)
Colorado (239)
Connecticut (260)
Europe (114123)
Florida (752)
Georgia (183)
Illinois (548)
Indiana (291)
Maryland (826)
Massachusetts (4078)
Michigan (225)
Minnesota (371)
New Jersey (1472)
New York (1479)
North Carolina (1006)
Northern California (2225)
Ohio (187)
Pennsylvania (1165)
South America (1649)
Southern California (1928)
Texas (775)
Utah (161)
Washington State (522)
There are 840,377 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
POSITIVE RESULTS FROM TEZSPIRE® (TEZEPELUMAB-EKKO) PHASE 3 WAYPOINT TRIAL HIGHLIGHT RAPID, SUSTAINED EFFECT IN CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
March 3, 2025
·
23 min read
Press Releases
Positive results from the TEZSPIRE Phase III WAYPOINT trial highlight rapid and sustained effect in chronic rhinosinusitis with nasal polyps
March 3, 2025
·
14 min read
Press Releases
Breakthrough! Exciting interim Phase II Data of LP-003 in CSU released by Longbio at AAAAI 2025
March 3, 2025
·
4 min read
Press Releases
Lexicon Pharmaceuticals to Announce Topline Results from Phase 2b PROGRESS Study Evaluating Pilavapadin (LX9211) in Adults with Diabetic Peripheral Neuropathic Pain
March 3, 2025
·
3 min read
Press Releases
Head-to-Head Against Pembrolizumab: Innovent Announces First Patient Dosed in the First Pivotal Study of IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Melanoma
March 3, 2025
·
8 min read
Press Releases
Pulnovo Medical Announces Closing of Nearly $100 Million Series C Financing
March 3, 2025
·
3 min read
Obesity
FDA, Other Experts Seek to Redefine Obesity and Prioritize Maintenance Treatment
Two recent documents—one from the FDA, the other from a commission organized by
The Lancet Diabetes & Endocrinology
—indicate an evolving mindset toward treating obesity as a chronic disease.
March 3, 2025
·
7 min read
·
Kate Goodwin
Cancer
The Search for the Next Keytruda: Immuno-Oncology’s Next Play
More than a decade after Merck’s Keytruda and BMS’ Yervoy ushered in the immuno-oncology revolution, the space is at a crossroads, with experts highlighting novel targets, combinations and pre-emptive immunization as the next wave for IO.
March 3, 2025
·
7 min read
·
Heather McKenzie
Press Releases
Phase III Study Shows Xolair May Be More Effective With Fewer Side Effects Than Oral Immunotherapy for the Treatment of Food Allergies
March 2, 2025
·
15 min read
Press Releases
CARsgen’s Claudin18.2 CAR-T Therapy Satri-cel Granted Breakthrough Therapy Designation by the NMPA
March 2, 2025
·
3 min read
1 of 84,038
Next
